Tuesday, February 27, 2024
Home Tags CSIR India and Laxai Life Sciences initiate clinical trials of promising repurposed drug Niclosamide for treatment of Covid-19

Tag: CSIR India and Laxai Life Sciences initiate clinical trials of promising repurposed drug Niclosamide for treatment of Covid-19

Skeletal formula of niclosamide. Created using ACD - ChemSketch 10.0, Inkscape, and vim.

CSIR India and Laxai Life Sciences initiate clinical trials of promising repurposed drug Niclosamide...

0
CSIR India and Laxai Life Sciences initiate clinical trials of promising repurposed drug Niclosamide for treatment of Covid-19 By PIB Delhi CSIR in collaboration with Laxai Life Sciences Pvt. Ltd., has initiated Phase-II clinical trial with...

Adblocker detected! Please consider reading this notice.

We've detected that you are using AdBlock Plus or some other adblocking software which is preventing the page from fully loading.

We don't have any banner, Flash, animation, obnoxious sound, or popup ad. We do not implement these annoying types of ads!

We need money to operate the site, and almost all of it comes from our online advertising.

Please add https://www.ibgnews.com to your ad blocking whitelist or disable your adblocking software.

×
error: Sorry Content is protected !!
Verified by MonsterInsights